Skip to main content

Featured

Honda Reaffirms Commitment to Canadian Auto Production Amid Tariff Concerns

Honda Canada has firmly denied reports suggesting it plans to shift car production from Ontario to the United States. The speculation arose from a Japanese news outlet's claim that Honda was considering relocating some of its manufacturing operations due to recent U.S. auto tariffs. However, Ontario Premier Doug Ford and federal officials have dismissed these claims as inaccurate. Honda Canada has assured that its Alliston, Ontario facility will continue to operate at full capacity, with no changes being considered at this time. The company remains committed to its Canadian operations, emphasizing that nearly 70% of Honda vehicles sold in Canada are manufactured domestically. Additionally, Honda is actively working on its North American electric vehicle strategy, which includes a $15 billion investment in Ontario to develop a full EV supply chain. Despite ongoing tariff challenges, Honda has reiterated its confidence in the Canadian market and its ability to navigate evolving trade...

article

Health Canada authorizes updated Pfizer-BioNTech COVID vaccine


Health Canada has authorized Pfizer-BioNTech’s updated COVID-19 vaccine for people six months and older.

The mRNA vaccine targets the Omicron XBB.1.5 subvariant that is circulating in Canada.

This is the second vaccine targeting XBB.1.5 that will be available in this country.

Earlier this month, Health Canada authorized Moderna's updated mRNA vaccine.

Both Pfizer and Moderna's shots are one-dose vaccines for people five years of age and older.

Three shots of the Pfizer vaccine is recommended for children between six months and four years of age who have not received their primary series of a COVID-19 vaccine.

Health Canada says it is currently reviewing an updated non-mRNA vaccine from Novavax.

Novavax’s vaccine has been submitted for consideration for people age 12 years and older.

Comments